Principal Securities’s Charles River Laboratories CRL Stock Holding History

Principal Securities’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.12M	Buy	6,500 +427	+7%	+$79.2K	0.02%	694
2025 Q4	$1.21M	Buy	6,073 +1,810	+42%	+$328K	0.02%	640
2025 Q3	$667K	Buy	4,263 +209	+5%	+$33.2K	0.01%	801
2025 Q2	$615K	Sell	4,054 -162	-4%	-$21.6K	0.01%	774
2025 Q1	$778K	Hold	4,216	–	–	0.02%	631
2024 Q4	$778K	Sell	4,216 -144	-3%	-$27.7K	0.02%	626
2024 Q3	$859K	Buy	4,360 +15	+0.3%	+$3.12K	0.02%	579
2024 Q2	$898K	Buy	4,345 +33	+0.8%	+$7.48K	0.02%	503
2024 Q1	$1.17M	Buy	4,312 +1,091	+34%	+$261K	0.04%	417
2023 Q4	$761K	Buy	+3,221	New	+$633K	0.03%	483

Other funds holding CRL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Principal Securities's CRL Position: Q1 2026 in Review

Principal Securities increased its Charles River Laboratories (CRL) stake by 7% in Q1 2026, buying an estimated $79.2K and bringing the position to 6,500 shares worth $1.12M. The position accounts for 0.02% of the portfolio, ranked #694.

Principal Securities first reported a position in CRL in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.21M in Q4 2025. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

Principal Securities held 6,500 shares of Charles River Laboratories worth $1.12M as of Q1 2026.
Principal Securities bought 427 Charles River Laboratories shares in Q1 2026, an estimated $79.2K.
Charles River Laboratories made up 0.02% of Principal Securities's portfolio in Q1 2026, its #694 holding.
Principal Securities first reported a position in Charles River Laboratories in Q4 2023 and has held it in 10 quarters since.
Principal Securities's Charles River Laboratories position peaked at $1.21M in Q4 2025.
557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Principal Securities's 13F filing for Q1 2026, filed 13 May 2026.